Navigation Links
Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin
Date:10/17/2011

SAN FRANCISCO, Oct. 17, 2011 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that the company's proprietary biochemical protein synthesis technology platform for the synthesis and manufacturing of novel protein therapeutics will be presented at the BioProduction 2011 conference in Berlin.

Trevor Hallam, Ph.D., chief scientific officer of Sutro, will present the capabilities of the company's platform as a design and production tool for hundreds of variants of potential protein therapeutics, including those with site-specifically incorporated non-natural amino-acids as well as those that cannot be synthesized with conventional technologies. Proteins can be expressed at research scale in a rapid parallel manner in several hours, and the linear scalability of the system allows for seamless and prompt scale up for use in clinical studies.  Sutro is establishing a current Good Manufacturing Practice (cGMP) facility for the production of clinical supplies of materials using their biochemical protein synthesis platform that will be on line in the first half of 2012. The featured presentation will take place at 4:20 p.m. CEST on Oct. 20.

"I am pleased to present Sutro's open, cell-free protein synthesis platform and its application to this broad audience at the BioProduction meeting," said Trevor Hallam, Ph.D. "Our technology platform enables the expression of proteins that cannot be expressed with other expression systems, including novel antibody-drug conjugates and other proteins with site-specific modifications. We are currently establishing our own drug pipeline and are also looking forward to discuss potential collaborations with new partners."

About Sutro Biopharma

Sutro Biopharma is a biopharmaceutical company that develops and designs novel protein therapeutics and biosuperiors that have site-directed
'/>"/>

SOURCE Sutro Biopharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
4. Ondine Biopharma Announces Second Quarter 2008 Financial Results
5. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
8. Therapure Biopharma Inc. opens for business with first client contracts
9. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
10. China Biopharma Effects 1 for 100 Reverse Stock Split
11. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Following the successful launch of On Demand ... introduce its new product and demonstrate its potential to ... in September, Formedix On Demand Services is the first ... tools. For the first time, these market-leading tools can ... Formations – a revolutionary new token-based payment system – ...
(Date:10/31/2014)... Stronger investment from private enterprises ... consumer electronics will help fuel new growth in ... IBISWorld has added a report on the Biometrics ... collection. , The Biometrics Scan Software industry comprises ... as fingerprint, iris, retina and face recognition identification ...
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Ardelyx, ... biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic ... quarter 2014 financial results on Thursday, November 6, ... will host a live conference call and webcast ... results and provide a business update. ...
(Date:10/30/2014)... October 30, 2014 Rancho BioSciences ... they have manually curated public data source TCGA ... customers. the data is now available for other ... unifies public and internal data sources for their Pharma, ... out of the data that becomes more easily accessible. ...
Breaking Biology Technology:Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Rancho BioSciences Manually Curated TCGA Data Sets Available 2
... Novavax, Inc. (Nasdaq: NVAX ) announced today ... company,s Chief Scientific Officer who will report to Dr. ...  Previously, Dr. Glenn was Chief Scientific Officer and founder of ... Johns Hopkins University,s School of Public Health and ...
... 2010 Olivier Bohuon will be,replacing Jean-Pierre Garnier ... , , , ... Olivier Bohuon , 51, was Executive Vice-President of the Abbott,Corporation and President ... Chicago ( $22 billion in sales).,In 2003, he was named ...
... , July 1 United Therapeutics Corporation ... (HKEx: 0950) announced today that they have entered into ... Injection in China .  Remodulin is a subcutaneously ... pulmonary arterial hypertension.  Lee,s Pharmaceutical is a leading Chinese ...
Cached Biology Technology:Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 2Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 3Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 4Olivier Bohuon Joins Pierre Fabre 2United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 2United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 3United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 4United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 5
(Date:10/28/2014)... This news release is available in German . ... our close relatives, the chimpanzees, acquire sufficient food when ... Taï National Park in Côte d,Ivoire researchers of the ... provide a clear example of how great apes can ... They show that chimpanzees make their sleeping nests more ...
(Date:10/28/2014)... announced awards to expand the Office of Rare ... Advancing Translational Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical ... scientists at 22 consortia will work with 98 ... investigate new treatments for patients with rare diseases. ... in fiscal 2014 funding from NIH. , Rett ...
(Date:10/28/2014)... in moving activity in a novel environment are ... according to an experimental study completed at the ... and Fisheries Research Institute. The study used novel, ... authentic angling trials to analyse if behaviours predict ... in traditional and enriched hatchery rearing environments. ...
Breaking Biology News(10 mins):The early chimp gets the fig 2The early chimp gets the fig 3NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3Fish 'personality' linked to vulnerability to angling 2
... importance of minorities took center stage during the Presidential ... representation in our educational and technological communities? ... majorities in science, technology, engineering and math (STEM) is ... of a trio of Presidential Award for Excellence in ...
... victims, a Michigan State University research team this month ... prevent a quarter-million African children from developing epilepsy each ... the anti-seizure medication levetiracetam, or LVT, for controlling seizures ... disease that affects brain function in some three million ...
... to ensure that the risk of lead being found in domestic ... further in line with new regulations which come into ... being conducted in collaboration with Yorkshire Water, and the findings could ... the USA, have similar issues with lead dissolved from plumbing. ...
Cached Biology News:Mentoring models to move minorities to majorities in STEM 2Mentoring models to move minorities to majorities in STEM 3MSU launches groundbreaking drug trial in Africa 2Research with Yorkshire Water to reduce lead in water supplies 2
Request Info...
QML offers standard and customized paraffin embedded tissue blocks....
Use our experts and resources to develop reagent systems for your applications....
Request Info...
Biology Products: